Menu Back toSession-0401-Statistical-Methods-for-Oncology-Clinical-Trials

The 7th DIA China Annual Meeting


Session 0401 Statistical Methods for Oncology Clinical Trials

Session Chair(s)

Ouhong  Wang, PhD, MBA

Ouhong Wang, PhD, MBA

  • Vice President, Biostatistics
  • Vertex Pharmaceuticals, United States

An Adaptive Seamless Phase IIIII Design for Oncology Trials with Subpopulation Selection Using Correlated Survival Endpoints

Speaker(s)

Jerry  Wu

An Adaptive Seamless Phase IIIII Design for Oncology Trials with Subpopulation Selection Using Correlated Survival Endpoints

Jerry Wu

  • Manager, Biostatistics
  • Amgen, China
Steve  Su

Flexible Modelling of Survival Curves for Censored Data in Oncology Trial

Steve Su

  • Senior Biostatistician, Statistics and Programmin
  • Covance, Australia, China
Chao  Zhu

Interval-censoring and its applications to oncology endpoint

Chao Zhu

  • Lilly Suzhou Pharmaceutical Co. Ltd., China, China
Fan  Xia, PhD

Statistical Considerations in Analyzing Disease with Recurrent Events

Fan Xia, PhD

  • Statistical Scientist
  • Roche, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650